-
View DetailHUMALOG insulin lispro 100 IU/mL injection multidose vial
Availability: Reduction in supply until supply is exhausted Deletion from market: 20 Jul 2026 -
View Detail
EPREX epoetin alfa 4000IU/0.4mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2026 -
View Detail
EPREX epoetin alfa (rch) 8000IU/0.8mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2026 -
View Detail
HUMULIN NPH human insulin 100IU/mL injection vial
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Aug 2026 -
View Detail
EPREX epoetin alfa 1000IU/0.5mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2026 -
-
View Detail
EPREX epoetin alfa (rch) 20000IU/0.5mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2026 -
View Detail
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection 10mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Jun 2026 -
View Detail
EPREX epoetin alfa (rch) 5000IU/0.5mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2026 -
View Detail
IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 100 mg/5 mL
Availability: Available -
View Detail
EPREX epoetin alfa 3000IU/0.3mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2026 -
View Detail
EPREX epoetin alfa (rch) 6000IU/0.6mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2026